EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling

Carrie Malcom iD, Ozlem Guzeloglu-Kayisli, Burak Un, Erika New, Busra Cetinkaya-Un, Xiaofang Guo, Emad Mikhail, Anthony Imudia, Charles Lockwood, Umit Kayisli

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Carrie Malcom und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, University of South Florida, Morsani College of Medicine, Tampa, FL 33606, USA. Hauptthemen laut MEDLINE: Uterine Neoplasms, Leiomyoma, Glucocorticoids, 11-beta-Hydroxysteroid Dehydrogenase Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

FK506-binding-protein-51 (FKBP51) is a glucocorticoid-induced co-chaperone protein previously shown to bind glucocorticoid receptor (GR), inhibiting its transcriptional activity. We previously found increased FKBP51 levels in uterine leiomyoma vs paired myometrium.

Objective

To test the hypothesis that elevated FKBP51 levels contribute to leiomyoma pathogenesis by altering GR signaling.

Design

RNA-sequencing was performed in leiomyoma cell cultures transfected with scramble or FKBP5-siRNA for 48 hours, then treated with vehicle or dexamethasone (DEX) for 24 hours. Differentially expressed genes, including HSD11B1, CNN1, and LAMA2 were analyzed by quantitative polymerase chain reaction. Hydroxysteroid 11-β dehydrogenase 1 (HSD11β1) expression was analyzed in leiomyoma, leiomyoma-adjacent paired myometrium, myometrium from patients without leiomyoma, and human endometrial stromal cells by quantitative polymerase chain reaction and immunohistochemistry.

Setting

University research institution. Patients Women with or without uterine leiomyoma. Main Outcome Measures HSD11B1 mRNA and protein levels in leiomyoma, paired myometrium, and normal myometrium.

Results

HSD11β1 expression was higher in paired myometrial and leiomyoma tissues vs normal myometrium (P < .02). DEX treatment increased HSD11B1 transcription in normal myometrial and human endometrial stromal cell cultures, but to a significantly greater extent in leiomyoma (P < .001). However, FKBP5-silencing blunted this DEX-induced HSD11B1 upregulation. DEX-treatment reduced LAMA2 and increased CNN1 levels (coding for extracellular matrix and smooth muscle proteins, respectively) in FKBP5-silenced vs scramble siRNA-transfected leiomyoma cultures.

Conclusion

FKBP51 not only inhibits but can augment GR-mediated transcription. Importantly, FKBP51-GR interactions increase HSD11B1 levels in leiomyoma cells, generating a pathological FKBP51-GR-HSD11β1 circle, altering transcription of downstream extracellular matrix and smooth muscle genes to induce a myofibroblast phenotype, thereby possibly contributing to leiomyoma pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine NeoplasmsLeiomyomaGlucocorticoids11-beta-Hydroxysteroid Dehydrogenase Type 1HumansFemaleTacrolimus Binding ProteinsSignal TransductionMyometriumAdultMiddle AgedGene Expression Regulation, NeoplasticDexamethasoneReceptors, GlucocorticoidTacrolimus Binding Protein 5

Stichwörter der Autor:innen

FKBP51HSD11β1gene expressionglucocorticoid signalingleiomyoma

Substanzen

Tacrolimus Binding ProteinsGlucocorticoids11-beta-Hydroxysteroid Dehydrogenase Type 1DexamethasoneReceptors, GlucocorticoidTacrolimus Binding Protein 5HSD11B1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics & Gynecology, University of South Florida, Morsani College of Medicine, Tampa, FL 33606, USA.
  • Shady Grove Fertility Center of Tampa Bay, Wesley Chapel, FL 33544, USA.

ORCID-Profile: Carrie Malcom

Zitieren

APA

Malcom, C., Guzeloglu-Kayisli, O., Un, B., New, E., Cetinkaya-Un, B., Guo, X., Mikhail, E., Imudia, A., Lockwood, C., & Kayisli, U. (2025). Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf255

Vancouver

Malcom C, Guzeloglu-Kayisli O, Un B, New E, Cetinkaya-Un B, Guo X, et al. Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf255

BibTeX
@article{Malcom2025,
  author = {Malcom, Carrie and Guzeloglu-Kayisli, Ozlem and Un, Burak and New, Erika and Cetinkaya-Un, Busra and Guo, Xiaofang and Mikhail, Emad and Imudia, Anthony and Lockwood, Charles and Kayisli, Umit},
  title = {Increased HSD11β1 Expression in Human Leiomyomatous Uteri: Implication for Enhanced Glucocorticoid Signaling},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf255}
}
Kostenlos starten →